Streetbeat News

Stock Prices

SNOW

Snowflake Inc. (NYSE:SNOW) shares are trading lower due to a reported data breach and mixed first-quarter results. The company beat revenue estimates but missed earnings expectations and lowered its margin forecasts due to AI infrastructure expenses. Despite this, Snowflake projects strong product revenue growth for the second quarter and full year. Analysts have mixed ratings, with an average 12-month price target suggesting potential upside.

Portfolio Pulse from Erica Kollmann

May 31, 2024 | 6:01 pm

AMGN

Amgen (NASDAQ:AMGN) has outperformed the market over the past 20 years with an average annual return of 8.86%, slightly above the market average. A $1000 investment in AMGN 20 years ago would be worth $5,457.95 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 6:00 pm

FCX

Freeport-McMoRan (NYSE:FCX) has significantly outperformed the market over the past 5 years, with an annualized return of 38.16%. A $1000 investment in FCX 5 years ago would now be worth $5,236.90.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 6:00 pm

EME

EMCOR Group (NYSE: EME) has seen a 22.39% increase in its short percent of float, now at 1.64% of all regular shares available for trading. This indicates a rise in bearish sentiment, although the company's short interest is still lower than its peers' average of 4.89%.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 6:00 pm

SIRI

Sirius XM Holdings (NYSE:SIRI) has seen a 10.53% increase in its short percent of float, now at 22.99%. This indicates a bearish sentiment among investors, as it would take 9.59 days to cover short positions. The company's short interest is significantly higher than its peers, whose average is 9.51%.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 6:00 pm

COST

Costco Wholesale Corporation (NASDAQ:COST) reported strong Q3 earnings, beating analyst estimates. Multiple analysts have raised their price targets, citing strong comparable sales, membership growth, and potential future catalysts like a membership fee hike and stock split.

Portfolio Pulse from Chris Katje

May 31, 2024 | 5:54 pm

Zscaler Inc (NASDAQ:ZS) reported better-than-expected third-quarter earnings, leading to a rise in its stock price. Multiple analysts have adjusted their price targets, with some maintaining positive ratings and others expressing caution due to macroeconomic challenges and sales attrition. The company showed strong demand, particularly in the Federal sector, and raised its guidance for the fourth quarter.

Portfolio Pulse from Anusuya Lahiri

May 31, 2024 | 5:46 pm

PAYC

Investors have taken a bullish position in Paycom Software (NYSE:PAYC) based on unusual options activity. Benzinga's options scanner identified 11 transactions, with a mix of bullish and bearish sentiments. The price target for PAYC ranges from $125 to $190, with significant open interest and volume trends. Analysts maintain a neutral stance with an average price target of $182.4.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 5:45 pm

COO

COST

CZR

DELL

DIA

GLD

GPS

MDB

MRVL

NTAP

QQQ

SPY

TLT

ULTA

VEEV

Tech stocks fell as Wall Street's 5-week rally ended, with the Nasdaq 100 dropping 1.5%. The S&P 500 and Russell 2000 also declined, while the Dow Jones rose. Concerns about economic slowdown and deceleration in personal spending and income contributed to the market's performance. Bonds and defensive stocks gained, with the iShares 20+ Year Treasury Bond ETF rising 0.6%. Gold and Bitcoin fell. Notable stock movements included MongoDB dropping 23% and The Gap rising 26% after earnings reports.

Portfolio Pulse from Piero Cingari

May 31, 2024 | 5:44 pm

CLDI

Calidi Biotherapeutics Inc (NASDAQ:CLDI) shares dropped by 30.7% to $0.21 after announcing a definitive agreement for the immediate exercise of Series B and C warrants to buy up to 10.698 million shares at 20 cents per share. This move is expected to generate approximately $2.1 million before fees and expenses. New unregistered warrants and Series B-1 and C-1 warrants will also be issued. The proceeds will fund clinical and pre-clinical programs, operating expenses, and working capital.

Portfolio Pulse from Henry Khederian

May 31, 2024 | 5:36 pm